SG48353A1 - Helicobacter pylori proteins useful for vaccines and diagnostics - Google Patents
Helicobacter pylori proteins useful for vaccines and diagnosticsInfo
- Publication number
- SG48353A1 SG48353A1 SG1996009100A SG1996009100A SG48353A1 SG 48353 A1 SG48353 A1 SG 48353A1 SG 1996009100 A SG1996009100 A SG 1996009100A SG 1996009100 A SG1996009100 A SG 1996009100A SG 48353 A1 SG48353 A1 SG 48353A1
- Authority
- SG
- Singapore
- Prior art keywords
- antigen
- helicobacter pylori
- vaccines
- diagnostics
- infection
- Prior art date
Links
- 241000590002 Helicobacter pylori Species 0.000 title abstract 5
- 229940037467 helicobacter pylori Drugs 0.000 title abstract 5
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 8
- 102000036639 antigens Human genes 0.000 abstract 8
- 108091007433 antigens Proteins 0.000 abstract 8
- 208000015181 infectious disease Diseases 0.000 abstract 3
- 101710112752 Cytotoxin Proteins 0.000 abstract 2
- 231100000599 cytotoxic agent Toxicity 0.000 abstract 2
- 239000002619 cytotoxin Substances 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 230000014726 immortalization of host cell Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITFI920052A IT1262895B (it) | 1992-03-02 | 1992-03-02 | Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico. |
| EPPCT/EP93/00158 | 1993-01-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG48353A1 true SG48353A1 (en) | 1998-04-17 |
Family
ID=11349982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG1996009100A SG48353A1 (en) | 1992-03-02 | 1993-03-02 | Helicobacter pylori proteins useful for vaccines and diagnostics |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6090611A (it) |
| EP (1) | EP0643770B1 (it) |
| JP (1) | JP4271952B2 (it) |
| AT (2) | ATE245698T1 (it) |
| IT (1) | IT1262895B (it) |
| SG (1) | SG48353A1 (it) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7141244B1 (en) * | 1992-03-02 | 2006-11-28 | Chiron Srl | Helicobacter pylori proteins useful for vaccines and diagnostics |
| AU3630093A (en) * | 1992-03-02 | 1993-10-05 | Biocine S.P.A. | Helicobacter pylori proteins useful for vaccines and diagnostics |
| ATE229978T1 (de) * | 1994-07-01 | 2003-01-15 | Chiron Corp | Helicobacter proteine und impstoffe |
| ES2283012T3 (es) * | 1996-01-04 | 2007-10-16 | Novartis Vaccines And Diagnostics, Inc. | Bacterioferritina de helicobacter pylori. |
| US20060269532A1 (en) * | 1997-02-25 | 2006-11-30 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US20030185830A1 (en) * | 1997-02-25 | 2003-10-02 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US20060024301A1 (en) * | 1997-02-25 | 2006-02-02 | Corixa Corporation | Prostate-specific polypeptides and fusion polypeptides thereof |
| US7517952B1 (en) * | 1997-02-25 | 2009-04-14 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| WO1999057278A2 (en) | 1998-04-30 | 1999-11-11 | Chiron S.P.A. | IMMUNIZATION AGAINST AND TREATMENT FOR INFECTION BY $i(H.PYLORI) |
| US6764687B1 (en) * | 1999-06-09 | 2004-07-20 | Akzo Nobel N.V. | Live attenuated bacteria for use in a vaccine |
| US7179609B1 (en) | 2000-10-04 | 2007-02-20 | Atrophus Ab | Screening method for gastritis |
| US7048931B1 (en) | 2000-11-09 | 2006-05-23 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
| US20020107368A1 (en) * | 2000-12-07 | 2002-08-08 | Jing-Hui Tian | Helicobacter proteins, gene sequences and uses thereof |
| EP1423142A1 (en) * | 2001-08-31 | 2004-06-02 | Chiron SRL. | Helicobacter pylori vaccination with a combination of caga, vaca and nap proteins |
| SE0200974D0 (sv) | 2002-03-27 | 2002-03-27 | Phagen Ab | Screening method for gastritis |
| US20060078919A1 (en) * | 2004-09-08 | 2006-04-13 | Harry C. Gurney Janice Gurney | Diagnostic test kit and methods of diagnosis and treatment of helicobacter SPP. associated infections |
| WO2006055623A2 (en) * | 2004-11-17 | 2006-05-26 | Drexel University | Method and compositions for prevention and treatment of malaria infections |
| EP1853914B1 (en) * | 2005-01-25 | 2015-04-22 | The Johns Hopkins University | Plasmodium diagnostic assay |
| ES2532942T3 (es) | 2006-03-01 | 2015-04-06 | Aduro Biotech | Listeria obtenida por ingeniería genética y métodos de uso de la misma |
| CN103415620B (zh) | 2010-11-17 | 2016-10-12 | 艾杜罗生物科技公司 | 诱导针对EGFRvIII的免疫应答的方法和组合物 |
| EA034702B1 (ru) | 2011-04-26 | 2020-03-10 | Молекулар Экспресс, Инк. | Липосомные композиции |
| IN2014MN02492A (it) | 2012-06-08 | 2015-07-17 | Aduro Biotech | |
| SG11201502770PA (en) | 2012-11-06 | 2015-06-29 | Aduro Biotech Inc | Facultatively attenuated bacterial species and methods of preparation and use thereof |
| AU2013358892B2 (en) | 2012-12-13 | 2018-06-21 | Aduro Biotech, Inc. | Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use |
| BR112015015076A2 (pt) | 2012-12-27 | 2018-10-30 | Aduro Biotech Inc | parceiros de fusão de peptídeo sinal que facilitam a expressão listerial de sequências antigênicas e métodos de preparação e uso dos mesmos. |
| SG10201708821RA (en) | 2013-04-29 | 2017-12-28 | Memorial Sloan Kettering Cancer Center | Compositions and methods for altering second messenger signaling |
| WO2014179760A1 (en) | 2013-05-03 | 2014-11-06 | The Regents Of The University Of California | Cyclic di-nucleotide induction of type i interferon |
| AP2015008700A0 (en) | 2013-05-18 | 2015-08-31 | Univ California | Compositions and methods for activating "stimulator of interferon gene"-dependent signalling |
| US9549944B2 (en) | 2013-05-18 | 2017-01-24 | Aduro Biotech, Inc. | Compositions and methods for inhibiting “stimulator of interferon gene”—dependent signalling |
| EP3027227A4 (en) | 2013-07-31 | 2018-05-23 | Memorial Sloan Kettering Cancer Center | Sting crystals and modulators |
| US10925945B2 (en) | 2014-10-13 | 2021-02-23 | Providence Health & Services-Oregon | Bacterial vaccines deficient in the 2-C-methyl-D-erythritol-4-phosphate pathway and methods of preparation and use thereof |
| WO2016073381A1 (en) | 2014-11-03 | 2016-05-12 | Cerus Corporation | Compositions and methods for improved car-t cell therapies |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5459041A (en) * | 1988-02-18 | 1995-10-17 | Enteric Research Laboratories, Inc. | Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection |
| US4882271A (en) * | 1988-03-10 | 1989-11-21 | Baylor College Of Medicine | Process for preparation of high molecular weight cell-associated protein of campylobacter pylori and use for serological detection of campylobacter pylori infection |
| FR2637612B1 (fr) * | 1988-10-06 | 1993-09-10 | Pasteur Institut | Sequences de nucleotides codant pour une proteine a activite ureasique |
| GB8928625D0 (en) * | 1989-12-19 | 1990-02-21 | 3I Res Expl Ltd | H.pylori dna probes |
| US5292658A (en) * | 1989-12-29 | 1994-03-08 | University Of Georgia Research Foundation, Inc. Boyd Graduate Studies Research Center | Cloning and expressions of Renilla luciferase |
| US5354854A (en) * | 1991-11-07 | 1994-10-11 | The Curators Of The University Of Missouri | Expression system for use in plants to suppress foreign expression and method |
| US5403924A (en) * | 1992-10-13 | 1995-04-04 | Vanderbilt University | Taga gene and methods for detecting predisposition to peptic ulceration |
-
1992
- 1992-03-02 IT ITFI920052A patent/IT1262895B/it active IP Right Grant
-
1993
- 1993-03-02 AT AT93905285T patent/ATE245698T1/de active
- 1993-03-02 SG SG1996009100A patent/SG48353A1/en unknown
- 1993-03-02 EP EP93905285A patent/EP0643770B1/en not_active Expired - Lifetime
- 1993-03-02 AT AT99202698T patent/ATE382692T1/de active
-
1995
- 1995-06-06 US US08/471,491 patent/US6090611A/en not_active Expired - Lifetime
-
2003
- 2003-01-16 JP JP2003008806A patent/JP4271952B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| IT1262895B (it) | 1996-07-22 |
| US6090611A (en) | 2000-07-18 |
| ITFI920052A1 (it) | 1993-09-02 |
| ITFI920052A0 (it) | 1992-03-02 |
| EP0643770A1 (en) | 1995-03-22 |
| ATE245698T1 (de) | 2003-08-15 |
| EP0643770B1 (en) | 2003-07-23 |
| ATE382692T1 (de) | 2008-01-15 |
| JP4271952B2 (ja) | 2009-06-03 |
| JP2003199567A (ja) | 2003-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG48353A1 (en) | Helicobacter pylori proteins useful for vaccines and diagnostics | |
| CA2131729A1 (en) | Helicobacter pylori proteins useful for vaccines and diagnostics | |
| MY119003A (en) | Bacterial antigens and vaccine compositions | |
| WO1990000594A3 (en) | Recombinant mycobacterial expression vehicles and uses therefor | |
| AU2001276619A1 (en) | Immunisation against chlamydia pneumoniae | |
| WO2003049762A3 (en) | Immunisation against chlamydia trachomatis | |
| DE69632536D1 (de) | Impfstoffe für das respiratorische-synzytial-virus mit nuklein säuren | |
| WO2000066739A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| JP2005097311A (ja) | 抗原 | |
| ES555124A0 (es) | Procedimiento de preparar particulas que contienen secuencias de aminoacidos y que tienen propiedades inmunogenas | |
| Minnick et al. | Cell entry and the pathogenesis of Bartonella infections | |
| DE69735207T2 (de) | Neuartiges, fibrinogen-bindendes protein, welches von einem koagulase-negativen staphylokokkus abstammt | |
| DE69737413D1 (en) | Bakterioferritin aus helicobacter pylori | |
| CA2190515A1 (en) | Vaccine against mycobacterial infections | |
| EP0294469A4 (en) | VACCINES AND DIAGNOSTIC ANALYSIS FOR HAEMOPHILUS INFLUENZAE. | |
| Ruscetti et al. | Polycythaemia-and anaemia-inducing strains of spleen focus-forming virus differ in post-translational processing of envelope-related glycoproteins | |
| NZ526879A (en) | Genes and proteins, and their use | |
| EP0603406A4 (en) | AVIAN MYCOPLASM ANTIGEN, ITS GENE, RECOMBINANT VECTOR CONTAINING SAID GENE, AND VACCINE PREPARED USING THE SAME. | |
| KR890008317A (ko) | 유전학적 조작에 의한 응고억제성 단백질 pp4의 제조방법 | |
| AU3379693A (en) | Vaccines and diagnostic assays for haemophilus influenzae | |
| EP2172214A3 (en) | Chlamydia antigens and corresponding DNA fragments and uses thereof | |
| DE69131319T2 (de) | Isoliertes PCTD Plasmid aus Chlamydia trachomatis von Serotyp D, dessen Genen und davon kodierten Proteine, rekombinante Plasmide für die Expression von deren Genen als Fusionsproteine in einem keterologen System, und ihre Verwendung als Impfstoff- und/oder Diagnostiekformulierung | |
| NZ242707A (en) | Nucleotide sequence and polypeptide of mareks disease virus and vaccine containing the polypeptide | |
| WO1995020658A3 (en) | Diagnosis and treatment of infections due to streptococci and enterococci | |
| Iwanaga et al. | Pili of Vibrio cholerae widely distributed in serogroup O1 strains |